Allarity Short Term Debt vs Long Term Debt Analysis

ALLR Stock

USD 1.10 0.01 0.90%

Allarity Therapeutics financial indicator trend analysis is way more than just evaluating Allarity Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Allarity Therapeutics is a good investment. Please check the relationship between Allarity Therapeutics Short Term Debt and its Long Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allarity Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Allarity Stock, please use our How to Invest in Allarity Therapeutics guide.

Short Term Debt vs Long Term Debt

Short Term Debt vs Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Allarity Therapeutics Short Term Debt account and Long Term Debt. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Allarity Therapeutics' Short Term Debt and Long Term Debt is 0.57. Overlapping area represents the amount of variation of Short Term Debt that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Allarity Therapeutics, assuming nothing else is changed. The correlation between historical values of Allarity Therapeutics' Short Term Debt and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Debt of Allarity Therapeutics are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Short Term Debt i.e., Allarity Therapeutics' Short Term Debt and Long Term Debt go up and down completely randomly.

Correlation Coefficient

0.57

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Short Term Debt

Long Term Debt

Long-term debt is a debt that Allarity Therapeutics has held for over one year. Long-term debt appears on Allarity Therapeutics balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Allarity Therapeutics balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most indicators from Allarity Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Allarity Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allarity Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

To learn how to invest in Allarity Stock, please use our How to Invest in Allarity Therapeutics guide.As of 11/29/2024, Issuance Of Capital Stock is likely to grow to about 18.6 M, while Tax Provision is likely to drop (318.1 K).

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	106K	60K	30K	46.9K
Total Operating Expenses	26.6M	16.9M	17.9M	17.8M

Reconciled Depreciation Total Operating Expenses

Allarity Therapeutics fundamental ratios Correlations

	Other Current Liab	Total Current Liabilities	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Inventory	Other Stockholder Equity	Total Current Assets	Common Stock	Property Plant Equipment	Other Liab	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Other Current Assets	Total Liab	Net Invested Capital
Other Current Liab		0.23	0.31	-0.02	-0.43	-0.06	0.08	-0.03	0.78	-0.03	-0.46	0.22	0.68	-0.36	0.18	-0.1	-0.89	0.85	0.28	0.85	-0.12	0.69	-0.08	-0.38	0.8	0.16
Total Current Liabilities	0.23		-0.72	-0.33	0.71	0.71	-0.16	-0.04	0.65	0.4	-0.35	0.16	0.15	-0.11	-0.06	-0.11	-0.33	0.32	-0.03	0.32	0.02	0.25	-0.11	-0.05	0.35	-0.07
Net Tangible Assets	0.31	-0.72		0.12	-0.71	-0.59	0.31	-0.11	-0.21	-0.46	-0.34	0.14	-0.03	0.01	-0.04	-0.01	0.0	0.0	-0.04	0.0	0.01	0.01	-0.02	0.03	0.02	-0.04
Retained Earnings	-0.02	-0.33	0.12		-0.54	0.28	0.68	-0.65	0.13	0.68	0.43	0.61	0.58	-0.55	0.91	0.91	0.02	-0.09	0.86	-0.09	-0.81	0.56	0.93	-0.67	-0.47	0.91
Accounts Payable	-0.43	0.71	-0.71	-0.54		0.53	-0.27	0.1	-0.05	0.09	-0.22	-0.1	-0.55	0.22	-0.48	-0.26	0.35	-0.32	-0.48	-0.32	0.38	-0.4	-0.28	0.38	-0.13	-0.47
Net Receivables	-0.06	0.71	-0.59	0.28	0.53		0.48	-0.68	0.46	0.81	-0.19	0.69	0.22	-0.44	0.37	0.58	0.09	-0.15	0.42	-0.15	-0.37	0.4	0.56	-0.39	-0.29	0.36
Inventory	0.08	-0.16	0.31	0.68	-0.27	0.48		-0.94	0.14	0.48	-0.21	0.93	0.26	-0.63	0.49	0.85	0.21	-0.3	0.57	-0.3	-0.49	0.53	0.82	-0.54	-0.47	0.47
Other Stockholder Equity	-0.03	-0.04	-0.11	-0.65	0.1	-0.68	-0.94		-0.19	-0.66	0.23	-0.96	-0.3	0.6	-0.54	-0.87	-0.25	0.35	-0.64	0.35	0.49	-0.48	-0.85	0.57	0.52	-0.52
Total Current Assets	0.78	0.65	-0.21	0.13	-0.05	0.46	0.14	-0.19		0.42	-0.35	0.4	0.72	-0.35	0.39	0.14	-0.82	0.79	0.41	0.79	-0.46	0.83	0.15	-0.38	0.6	0.38
Common Stock	-0.03	0.4	-0.46	0.68	0.09	0.81	0.48	-0.66	0.42		0.2	0.65	0.56	-0.55	0.81	0.8	-0.01	-0.06	0.8	-0.06	-0.64	0.49	0.81	-0.67	-0.38	0.81
Property Plant Equipment	-0.46	-0.35	-0.34	0.43	-0.22	-0.19	-0.21	0.23	-0.35	0.2		-0.37	0.15	-0.04	0.37	0.23	0.12	-0.13	0.31	-0.13	-0.2	-0.1	0.26	-0.2	-0.29	0.38
Other Liab	0.22	0.16	0.14	0.61	-0.1	0.69	0.93	-0.96	0.4	0.65	-0.37		0.37	-0.63	0.55	0.81	0.06	-0.15	0.61	-0.15	-0.55	0.62	0.79	-0.57	-0.35	0.53
Total Assets	0.68	0.15	-0.03	0.58	-0.55	0.22	0.26	-0.3	0.72	0.56	0.15	0.37		-0.56	0.78	0.45	-0.72	0.66	0.84	0.66	-0.59	0.82	0.49	-0.76	0.36	0.77
Short Long Term Debt Total	-0.36	-0.11	0.01	-0.55	0.22	-0.44	-0.63	0.6	-0.35	-0.55	-0.04	-0.63	-0.56		-0.54	-0.66	0.23	-0.08	-0.7	-0.08	0.18	-0.63	-0.66	0.92	0.04	-0.5
Total Stockholder Equity	0.18	-0.06	-0.04	0.91	-0.48	0.37	0.49	-0.54	0.39	0.81	0.37	0.55	0.78	-0.54		0.81	-0.23	0.17	0.94	0.17	-0.82	0.63	0.84	-0.75	-0.25	1.0
Property Plant And Equipment Net	-0.1	-0.11	-0.01	0.91	-0.26	0.58	0.85	-0.87	0.14	0.8	0.23	0.81	0.45	-0.66	0.81		0.2	-0.29	0.82	-0.29	-0.69	0.53	1.0	-0.7	-0.6	0.8
Net Debt	-0.89	-0.33	0.0	0.02	0.35	0.09	0.21	-0.25	-0.82	-0.01	0.12	0.06	-0.72	0.23	-0.23	0.2		-0.99	-0.25	-0.99	0.2	-0.67	0.17	0.31	-0.88	-0.22
Cash	0.85	0.32	0.0	-0.09	-0.32	-0.15	-0.3	0.35	0.79	-0.06	-0.13	-0.15	0.66	-0.08	0.17	-0.29	-0.99		0.16	1.0	-0.2	0.6	-0.26	-0.17	0.9	0.16
Non Current Assets Total	0.28	-0.03	-0.04	0.86	-0.48	0.42	0.57	-0.64	0.41	0.8	0.31	0.61	0.84	-0.7	0.94	0.82	-0.25	0.16		0.16	-0.67	0.68	0.85	-0.89	-0.18	0.93
Cash And Short Term Investments	0.85	0.32	0.0	-0.09	-0.32	-0.15	-0.3	0.35	0.79	-0.06	-0.13	-0.15	0.66	-0.08	0.17	-0.29	-0.99	1.0	0.16		-0.2	0.6	-0.26	-0.17	0.9	0.16
Common Stock Shares Outstanding	-0.12	0.02	0.01	-0.81	0.38	-0.37	-0.49	0.49	-0.46	-0.64	-0.2	-0.55	-0.59	0.18	-0.82	-0.69	0.2	-0.2	-0.67	-0.2		-0.66	-0.71	0.33	0.23	-0.84
Non Current Liabilities Total	0.69	0.25	0.01	0.56	-0.4	0.4	0.53	-0.48	0.83	0.49	-0.1	0.62	0.82	-0.63	0.63	0.53	-0.67	0.6	0.68	0.6	-0.66		0.54	-0.64	0.34	0.61
Capital Lease Obligations	-0.08	-0.11	-0.02	0.93	-0.28	0.56	0.82	-0.85	0.15	0.81	0.26	0.79	0.49	-0.66	0.84	1.0	0.17	-0.26	0.85	-0.26	-0.71	0.54		-0.72	-0.58	0.83
Other Current Assets	-0.38	-0.05	0.03	-0.67	0.38	-0.39	-0.54	0.57	-0.38	-0.67	-0.2	-0.57	-0.76	0.92	-0.75	-0.7	0.31	-0.17	-0.89	-0.17	0.33	-0.64	-0.72		0.04	-0.71
Total Liab	0.8	0.35	0.02	-0.47	-0.13	-0.29	-0.47	0.52	0.6	-0.38	-0.29	-0.35	0.36	0.04	-0.25	-0.6	-0.88	0.9	-0.18	0.9	0.23	0.34	-0.58	0.04		-0.27
Net Invested Capital	0.16	-0.07	-0.04	0.91	-0.47	0.36	0.47	-0.52	0.38	0.81	0.38	0.53	0.77	-0.5	1.0	0.8	-0.22	0.16	0.93	0.16	-0.84	0.61	0.83	-0.71	-0.27

Click cells to compare fundamentals

Allarity Therapeutics Account Relationship Matchups

Allarity Therapeutics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Current Liab	1.9M	1.8M	19.8M	2.3M	4.4M	6.5M
Total Current Liabilities	4.7M	5.5M	20.7M	11.2M	14.2M	11.7M
Net Tangible Assets	(32.1M)	(15.1M)	(10.0M)	(7.7M)	(8.8M)	(9.2M)
Retained Earnings	(32.4M)	(37.4M)	(66.5M)	(82.6M)	(94.5M)	(99.2M)
Accounts Payable	2.2M	2.1M	698K	6.3M	8.4M	5.5M
Net Receivables	1.7M	1.1M	1.3M	871K	946K	898.7K
Other Stockholder Equity	50.6M	62.5M	84.4M	83.2M	90.4M	58.3M
Total Current Assets	3.3M	1.7M	21.1M	5.0M	2.0M	1.9M
Common Stock	924K	1.6M	810K	2K	1.8K	1.7K
Property Plant Equipment	2.9M	2.1M	94K	21K	18.9K	18.0K
Other Liab	6.1M	2.3M	9.1M	349K	314.1K	298.4K

Pair Trading with Allarity Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allarity Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allarity Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Allarity Stock

0.68

ELAN

Elanco Animal Health

Pair Corr

Moving against Allarity Stock

0.88	BHC	Bausch Health Companies	Pair Corr
0.87	EWTX	Edgewise Therapeutics	Pair Corr
0.82	GILD	Gilead Sciences	Pair Corr
0.72	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.71	GANX	Gain Therapeutics	Pair Corr

The ability to find closely correlated positions to Allarity Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allarity Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allarity Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allarity Therapeutics to buy it.

The correlation of Allarity Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allarity Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allarity Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Allarity Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Allarity Stock Analysis

When running Allarity Therapeutics' price analysis, check to measure Allarity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allarity Therapeutics is operating at the current time. Most of Allarity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Allarity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allarity Therapeutics' price. Additionally, you may evaluate how the addition of Allarity Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC